Showing results (1931-1940 of 2,079) with videos related to

Sort By:
Pageof 208
Research (Washington, D.C.)|March 30, 2026
CHAtRF Modulates Cardiac Hypertrophy via SRSF5-Dependent Regulation of Psmg4 Alternative SplicingLu-Yu Zhou, Kai Wang, Ying-Hui Li, et al.
Zhonghua Yi Xue Za Zhi|January 19, 2013
[Prognostic value of maximum standard uptake on pretreatment 18F-FDG PET/CT scan in newly diagnosed diffuse large B cell lymphoma]Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Annals of Hematology|November 1, 2017
Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphomaWei Ping Liu, Xiao Pei Wang, Wen Zheng, et al.
Acta Pharmacologica Sinica|June 30, 2025
PYRCR alleviates myocardial ischemia/reperfusion injury in mice via inhibiting DRG2-mediated cardiomyocyte pyroptosisXin-Zhe Chen, Hong-Fei Xu, Xue-Mei Zhao, et al.
Differentiation; Research in Biological Diversity|January 15, 2013
The expression of calcium-sensing receptor in mouse embryonic stem cells (mESCs) and its influence on differentiation of mESC into cardiomyocytesJian Sun, Wen He, Shu-zhi Bai, et al.
Trials|August 25, 2020
Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trialZong-Yu Wang, Shou-Zhi Fu, Liang Xu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 16, 2011
[The effects of aerobic exercise on cardiac output during exercise in patients with chronic heart failure]Yu-qin Shen, Jin-fa Jiang, Le-min Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 7, 2013
[Prognostic value of (18)F-FDG PET/CT after first-line treatment in patients with diffuse large B cell lymphoma]Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2021
Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid CarcinomaYu Qin, Jennifer R Wang, Ying Wang, et al.
Molecular Cancer Therapeutics|January 23, 2014
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancerMaoyong Fu, Erin L Maresh, Gustavo F Helguera, et al.
Pageof 208